Tau protein aggregation is associated with cellular senescence in the brain.

Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q, Orr ME. · 2018

Read Tau protein aggregation is associated with cellular senescence in the brain. by Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q, Orr ME. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6260915.txt.

Introduction

Musi and co-authors link clumps of tau protein in the brain to cell senescence. Their study appeared in Aging Cell. Tau tangles mark Alzheimer's disease and over twenty related disorders. Tangle load tracks memory loss more closely than other signs. Yet tangles do not seem to kill cells directly. The team read gene patterns in tangle bearing nerve cells from human brains.

Those patterns matched senescence, a stress state where cells stop dividing and change their work. Four mouse models showed the same link for tangles, but not for amyloid plaques. A marker gene rose in step with tangle load and brain shrinkage. Human tissue from another tau disease showed the pattern too. Drugs that clear senescent cells cut tangle counts in mice. Neuron loss and brain swelling also eased. The work names a new target class for tau diseases.

Catalog record

CREATORMusi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q, Orr ME.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6260915

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Tau protein aggregation is associated with cellular senescence in the brain By Nicolas Musi, Joseph M. Valentine, Kathryn R. Sickora, Eric Baeuerle, Cody S. Thompson, Qiang Shen, Miranda E. Orr Published in: Aging Cell DOI: 10.1111/acel.12840 ABSTRACT Abstract Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI), and over twenty others. Tau‐containing neurofibrillary tangle (NFT) accumulation is the closest correlate with cognitive decline and cell loss (Arriagada, Growdon, Hedley‐Whyte, & Hyman, 1992), yet mechanisms mediating tau toxicity are poorly understood. NFT formation does not induce apoptosis (de Calignon, Spires‐Jones, Pitstick, Carlson, & Hyman, 2009), which suggests that secondary mechanisms are driving toxicity. Transcriptomic analyses of NFT‐containing neurons microdissected from postmortem AD brain revealed an expression profile consistent with cellular senescence. This complex stress response induces aberrant cell cycle activity, adaptations to maintain survival, cellular remodeling, and metabolic dysfunction. Using four AD transgenic mouse models, we found that NFTs, but not Aβ plaques, display a senescence‐like phenotype. Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice. This relationship extended to postmortem brain tissue from humans with PSP to indicate a phenomenon common to tau toxicity. Tau transgenic mice with late‐stage pathology were treated with senolytics to remove senescent cells. Despite the advanced age and disease progression, MRI brain imaging and histopathological analyses indicated a reduction in total NFT density, neuron loss, and ventricular enlargement. Collectively, these findings indicate a strong association between the presence of NFTs and cellular senescence in the brain, which contributes to neurodegeneration. Given the prevalence of tau protein deposition among neurodegenerative diseases, these findings have broad implications for understanding, and potentially treating, dozens of brain diseases. INTRODUCTION The underlying processes driving chronic neurodegeneration in Alzheimer’s disease (AD) and related neurodegenerative disorders are largely unknown, and disease‐modifying treatments remain elusive. The accumulation of tau protein is the most common pathology among these diseases making tau an appealing molecular target for intervention (Orr, Sullivan, & Frost, 2017). Tau‐containing neurofibrillary tangles (NFTs) closely track with disease severity in human AD (Arriagada, Growdon, Hedley‐Whyte, & Hyman, 1992); however, NFT‐containing neurons are long‐lived and do not induce immediate cell death (de Calignon, Spires‐Jones, Pitstick, Carlson, & Hyman, 2009). In silico modeling predicts that NFT‐containing neurons may survive decades (Morsch, Simon, & Coleman, 1999), which suggests that non‐cell autonomous mechanisms may contribute to NFT‐associated toxicity. The experimental data from various studies indicate that tau pathology may be associated with cellular senescence. This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction, and disruption of surrounding tissue due to the secretion of toxic molecules (Childs et al., 2016). While many of these features have been described in AD brains and transgenic animal models throughout the literature (e.g., aberrant cell cycle activity, p16INK4A co‐localization with NFTs (Arendt, Rodel, Gartner, & Holzer, 1996), decreased lamin B1, and heterochromatin relaxation (Frost, Bardai, & Feany, 2016); a role for cellular senescence in AD‐associated neurodegeneration has not been investigated. We hypothesized that tau accumulation may activate this stress response and thereby initiate a chronic degenerative process culminating in neuron loss and brain dysfunction. To test this hypothesis, we examined human brain tissue with NFT pathology and utilized AD transgenic mouse models that develop tau‐associated pathologies. Also, we employed methods to genetically reduce NFTs and pharmacologically clear senescent cells. Our results indicate that NFTs induce cellular senescence in transgenic mice and postmortem human brain tissue. We also found that senolytics decreased cortical NFT burden, brain atrophy, and neuron loss in an advanced age (20 months old) transgenic mouse model of tau‐associated neurodegeneration. RESULTS NFT‐bearing neurons from postmortem AD brain tissue displayed a senescence‐like transcriptomic profile We queried the publicly available GEO Profiles database (Barrett et al., 2013) for gene sets specific to NFTs. We evaluated laser capture‐microdissected cortical neurons containing NFTs from AD brains (GEO accession GDS2795) and compared them to adjacent histopathologically normal neurons for a within‐subject study design (Dunckley et al., 2006). NFT‐containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis, and cell death pathways (Figure 1a). NFκB, a pro‐survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B, and CXCL1 (Figure 1b). Collectively, the molecular pathways identified in the NFT analyses resembled cellular senescence. [Figure: Neurofibrillary tangles were associated with cellular senescence‐associated gene pathways in human Alzheimer’s disease neurons and tau transgenic mouse brains. (a) Pathways and predicted upstream regulators identified by ingenuity pathway analyses (IPA, QIAGEN) as significantly enriched in Alzheimer’s disease patient‐derived neurons with neurofibrillary tangles compared to non‐tangle‐containing neurons; z‐score plotted on x‐axis and (p‐value) indicated in bar graph. Cellular functions and (b) predicted upstream regulators employed by neurofibrillary tangle‐containing neurons derived from Alzheimer’s disease patient are shown. (c) Predicted upstream regulators of gene transcription in tauNFT mice after the onset of neurofibrillary tangles (~6 months old vs. ~2 months old); z‐score plotted on x‐axis and (p‐value) indicated in bar graph. (d‐e) Representative immunoblot generated by capillary electrophoresis on chromatin‐bound fractions from mouse forebrain homogenate probed with anti‐γ‐H2ax antibody. (e) Densitometric normalization of γ‐H2ax to total protein content (CTL: n = 3; tauWT n = 4; tauNFT: n = 5; ANOVA, p = 0.0056. Mice aged 16 to 18 months old). (f–g) Quantitative gene expression on RNA isolated from CTL (open bar, n = 3), tauWT (closed bar, n = 3), and tauNFT (red bar, n = 4) mouse forebrain targeting (f): Cdkn2a, p = 0.0066, and (g) Cdkn1a, p = 0.0207. Gene expression was analyzed by one‐way ANOVA Tukey’s multiple comparison post hoc. Data are graphically represented as mean ± SEM] NFTs were associated with a senescence‐associated transcriptomic profile in tau transgenic mice We used the rTg(tauP301L)4510 transgenic mouse line, hereon referred to as “tauNFT” to investigate a link between NFT formation and a senescence‐like phenomenon in neurodegeneration. These mice develop well‐characterized, aggressive, tau pathology in forebrain regions concomitant with neurodegeneration and cognitive deficits (Santacruz et al., 2005; pathology illustrated in Supporting Information Figure S1). Mice that overexpress wild‐type human tau, “tauWT,” express the same level of transgenic human tau protein as tauNFT, but acquire age‐dependent tau pathogenesis at a much slower rate and are used to identify effects of elevated pre‐pathogenic tau (Hoover et al., 2010; Supporting Information Figures S1 and S2); age‐matched tauNFT littermate mice without human tau overexpression serve as wild‐type controls, “CTL”. To determine whether NFT‐containing neurons in mice induced a gene expression profile resembling cellular senescence, we assessed hippocampal gene expression patterns in tauNFT mice before (~2 months old) and after (~6 months old) NFT formation (GSE56772). Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, and IL‐1B, as well as enrichment in other senescence‐associated JAK, STAT, CDKN2A, and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis. Evidence of DNA damage, SASP, and NFκB activation were associated with NFTs Senescence‐inducing stressors often inflict DNA damage

Read the complete text